Springer Nature AG & Co. KGaA: directors' dealings · Germany · BaFin

About Springer Nature AG & Co. KGaA

Springer Nature AG & Co. KGaA is one of the world’s leading publishers of research, health and education content. Listed in Germany on Xetra/Frankfurt (DAX/MDAX/SDAX), in the country Germany, the company is relevant to investors looking for exposure to a high-quality information services model with recurring demand, structural growth in open access, and strong long-term brand equity. The group was formed in May 2015 through the combination of Nature Publishing Group, Macmillan Education and Springer Science+Business Media, but its heritage goes back much further: Springer was founded in Berlin in 1842, Macmillan in 1843, and Nature was first published in 1869. Today, Springer Nature is a globally recognized academic publisher with flagship brands including Springer, Nature Portfolio, BMC, Palgrave Macmillan and Scientific American. Its business model is built around three main segments. Research publishes scientific journals, books and digital platforms for researchers, universities, libraries and research funders. Health provides medical and pharmaceutical information products and services for healthcare professionals. Education covers textbooks, digital learning content and educational solutions used by schools, universities and teachers. Revenue therefore comes from a mix of subscriptions, open access publishing, licensing, book sales and technology-enabled services. From a competitive standpoint, Springer Nature is one of the strongest global players in scholarly publishing. Its advantages include premium brands, deep editorial expertise, a broad content portfolio and an increasingly effective ability to monetise the shift toward open access. The company is also investing heavily in technology and AI across the publishing workflow, including manuscript screening, editorial evaluation, peer-review support and research integrity tools. That should help improve author experience, operational efficiency and retention while strengthening the moat around its publishing ecosystem. Geographically, Springer Nature has a truly international footprint, with major hubs in Berlin, London and New York, alongside a broad network of editorial, commercial and technology teams around the world. Its corporate home and historic roots are in Germany, which makes it a notable German listed asset for francophone investors seeking a defensive but innovation-linked business. Recent highlights include a strong 2025 performance, with revenue growth and continued momentum in Research, supported by open access. In early 2026, the group launched new editorial initiatives such as the Nature Progress series and highlighted broader deployment of AI tools across publishing. Overall, Springer Nature continues to combine academic heritage, digital transformation and disciplined execution.